Hamidreza Montazeri Aliabadi Selected Research

2- phenyl- 5,5- dimethyltetrahydro- 1,4- oxazine

8/2022

Combinational silencing of components involved in JAK/STAT signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hamidreza Montazeri Aliabadi Research Topics

Disease

7	Neoplasms (Cancer) 08/2022 - 10/2011
5	Breast Neoplasms (Breast Cancer) 01/2021 - 10/2011
4	Triple Negative Breast Neoplasms 08/2022 - 12/2016
1	Exanthema (Rash) 01/2018

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 08/2022 - 10/2011
5	Small Interfering RNA (siRNA)IBA 08/2022 - 10/2011
2	LipidsIBA 12/2016 - 10/2011
2	SurvivinIBA 12/2016 - 10/2011
1	2- phenyl- 5,5- dimethyltetrahydro- 1,4- oxazineIBA 08/2022
1	Amino Acids FDA Link 04/2019
1	Cyclic PeptidesIBA 04/2019
1	1,2-dielaidoylphosphatidylethanolamine (Lipofectin)IBA 04/2019
1	Peptides (Polypeptides)IBA 04/2019
1	ruxolitinibIBA 01/2019
1	Everolimus FDA Link 01/2019
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	Hyaluronic Acid (Hyaluronan)IBA 01/2018
1	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 01/2018
1	PolyethyleneimineIBA 12/2016
1	Cell Cycle ProteinsIBA 12/2016
1	Biocompatible Materials (Biomaterials)IBA 12/2016
1	PolymersIBA 12/2016

Therapy/Procedure

4	Therapeutics 01/2019 - 10/2011
1	Adjuvant Chemotherapy 01/2018
1	Complementary Therapies (Alternative Medicine) 12/2016